Helius Medical Technologies (HSDT) - Kapitalizatsiyaning foydaga nisbati
Helius Medical (HSDT) portativ PoNS tizimlarini ishlab chiqadi, bunda apparat sotuvlari yuqori marjali SaaS terapiya qo'llab-quvvatlash xizmati bilan to'ldiriladi. -0.70 metriki bilan bog'liq narxlar dinamikasi tarixi ushbu o'tishni vizuallashtiradi. Biotexnologiya kompaniyasining muvaffaqiyati sug'urta to'lovlari va insultdan keyingi reabilitatsiya qurilmalarining sinov natijalariga bog'liq. Nevrologik markazlar tarmog'ining kengayishi va tartibga soluvchi organlar tasdiqlari bilan birga non-invaziv modulyatsiyaga bo'lgan talab ortib bormoqda.
Helius Medical kompaniyasining tahliliy kesimlari
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati Helius Medical|HSDT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Helius Medical Technologies Inc.|HSDT - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Helius Medical Technologies, Inc.|HSDT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Helius Medical Technologies|Shoshilinch likvidlik heliusmedical.com
- foyda va bozor koeffitsiyentlari statistikasi:
HSDT - Sof foyda|Sof foyda prognozi Helius Medical|HSDT - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Helius Medical Technologies Inc.|HSDT - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Helius Medical Technologies, Inc.|HSDT - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Helius Medical Technologies|HSDT - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi heliusmedical.com|HSDT - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Helius Medical
Kompaniyaning umumiy tahlili:heliusmedical.com - HSDT
Helius Medical (HSDT) non-invaziv terapiya segmentida monopol pozitsiyani saqlab qolmoqda, bu esa kompaniyaga PoNS qurilmalari narxiga yuqori premiumni kiritish imkonini beradi va bevosita biznesning bozor qiymatiga ta'sir qiladi. Kompaniyaning P/E tebranishlarini tahlil qilish orqali investorlar joriy bozor kapitalizatsiyasini sof foyda bilan solishtirib, aktivning spekulyativ narxi va uning aksiya uchun foyda keltirishning haqiqiy qobiliyati o'rtasidagi farqni aniqlaydilar.
Raqobatdosh kompaniyalar tahlili
BIIB: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NBIX|RGC - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|ACADIA Corp - Narxning foydaga nisbati|Xenon Pharmaceuticals - P/E multiplikatori|Biznesning o‘zini qoplash muddati vikingtherapeutics.com VKTX|SUPN (Supernus) - Narx-foyda koeffitsiyenti|Catalyst Pharma (CPRX) - P/E multiplikatori|Narxning foydaga nisbati Denali Therapeutics Inc|Harmony Corp (HRMY) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti BHVN (Biohaven Ltd.)|AMLX (amylyx.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|PRAX - Narx-foyda koeffitsiyenti|Anavex Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CeriBell EEG|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon) - P/E multiplikatori|Omeros Corp. (OMER) - Biznesning o‘zini qoplash muddati|P/E multiplikatori NGNE|Narx-foyda koeffitsiyenti AC Immune Inc ACIU|P/E multiplikatori VYGR (Voyager Therapeutics)|P/E multiplikatori neumoratx.com NMRA|SCLX - Narxning foydaga nisbati|TVGN: Narxning foydaga nisbati|ACOG: P/E multiplikatori|Cognition Therapeutics Inc. - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Inhibikase Therapeutics|cassavasciences.com (SAVA) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ASRT|coyatherapeutics.com - Narx-foyda multiplikatori|Vistagen - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati OVID (Ovid Therapeutics Inc)|ABOS - Narxning foydaga nisbati|CRVO (cervomed.com) - Narx-foyda multiplikatori|ATHE: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Clene (CLNN)|Narx-foyda koeffitsiyenti PEPG|P/E multiplikatori Jupiter Neurosciences, Inc.|Narxning foydaga nisbati Relmada Therapeutics (RLMD)|ANVS (annovisbio.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Grace Therapeutics GRCE|Firefly Neuroscience, Inc. (AIFF) - Kapitalizatsiyaning foydaga nisbati|ANEW Medical, Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati NRSN (NeuroSense Therapeutics)|RVPH: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati MetaVia (MTVA)|Narxning foydaga nisbati NeurAxis|Narxning foydaga nisbati PASG|P/E multiplikatori NEUP|Biznesning o‘zini qoplash muddati Minerva|Athira Pharma, Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori addextherapeutics.com ADXN|ALZN - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Cyclerion Therapeutics CYCN|PTIX (protagenic.com) - Narx-foyda koeffitsiyenti|Pasithea Therapeutics Corp. - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Cortigent Inc|Narx-foyda koeffitsiyenti avenuetx.com (ATXI)|P/E multiplikatori BCLI|CARA - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori CHRO (Chromocell Therapeutics Corporation)|ELYM: Narx-foyda multiplikatori|Intra-Cellular - P/E multiplikatori|Biznesning o‘zini qoplash muddati longboardpharma.com LBPH|MRNS: P/E multiplikatori|Narx-foyda koeffitsiyenti NKGen Biotech Inc|NRBO (NeuroBo) - P/E multiplikatori|P/E multiplikatori Sage Therapeutics Inc|Narxning foydaga nisbati Synaptogenix, Inc. (SNPX)|Narxning foydaga nisbati TRVN (trevena.com)|P/E multiplikatori VIGL (Vigil Neuroscience, Inc.)|Kompaniya qiymatining sof foydaga nisbati WENA|CERE - Narxning foydaga nisbati
